A Phase IV, Randomized, Interventional, Study to Assess Subject Treatment Session Perception and InvestigatorTreatment Experience of Alluzience and Vacuum-Dried Botulinum Neurotoxin Type A for Aesthetic Use
Latest Information Update: 21 Feb 2024
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Glabellar lines
- Focus Therapeutic Use
- Acronyms STAR
- Sponsors Q-Med
Most Recent Events
- 17 Jan 2024 According to Galderma Media Release, data from this study will be presented at the upcoming TOXINS 2024 conference in Berlin, held from January 17-20, 2024.
- 22 Jun 2023 Status changed from active, no longer recruiting to completed.
- 20 Jan 2023 According to a Galderma media release, data from this study will be presented at the International Master Course on Aging Science (IMCAS) World Congress 2023